Medical Properties Trust, Inc. (NYSE:MPW) Receives $5.25 Average Target Price from Analysts

Shares of Medical Properties Trust, Inc. (NYSE:MPWGet Free Report) have earned a consensus rating of “Hold” from the eight analysts that are currently covering the firm, MarketBeat.com reports. Seven investment analysts have rated the stock with a hold recommendation and one has assigned a buy recommendation to the company. The average twelve-month target price among analysts that have issued a report on the stock in the last year is $5.25.

MPW has been the subject of several research reports. Mizuho reduced their price objective on Medical Properties Trust from $6.00 to $5.00 and set a “neutral” rating for the company in a report on Thursday, December 5th. Wolfe Research upgraded shares of Medical Properties Trust to a “hold” rating in a research report on Monday, September 23rd. Colliers Securities upgraded shares of Medical Properties Trust from a “neutral” rating to a “buy” rating and set a $6.50 target price for the company in a report on Friday, September 13th. Finally, Truist Financial lifted their target price on shares of Medical Properties Trust from $5.00 to $6.00 and gave the stock a “hold” rating in a research report on Friday, September 13th.

Get Our Latest Report on Medical Properties Trust

Medical Properties Trust Price Performance

MPW stock opened at $3.99 on Wednesday. The firm has a 50 day moving average of $4.53 and a 200-day moving average of $4.81. The company has a market cap of $2.39 billion, a price-to-earnings ratio of -0.94, a PEG ratio of 0.64 and a beta of 1.29. The company has a current ratio of 2.38, a quick ratio of 2.38 and a debt-to-equity ratio of 1.69. Medical Properties Trust has a 12-month low of $2.92 and a 12-month high of $6.55.

Medical Properties Trust Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Thursday, January 9th. Shareholders of record on Thursday, December 12th will be paid a dividend of $0.08 per share. The ex-dividend date is Thursday, December 12th. This represents a $0.32 annualized dividend and a dividend yield of 8.03%. Medical Properties Trust’s dividend payout ratio is currently -7.58%.

Insider Activity

In related news, Director Michael G. Stewart sold 32,780 shares of the company’s stock in a transaction on Wednesday, October 9th. The stock was sold at an average price of $5.46, for a total value of $178,978.80. Following the completion of the transaction, the director now directly owns 221,245 shares in the company, valued at approximately $1,207,997.70. This represents a 12.90 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Elizabeth N. Pitman purchased 8,087 shares of the firm’s stock in a transaction on Wednesday, September 18th. The stock was acquired at an average cost of $6.01 per share, for a total transaction of $48,602.87. Following the completion of the purchase, the director now owns 76,740 shares in the company, valued at $461,207.40. The trade was a 11.78 % increase in their position. The disclosure for this purchase can be found here. Company insiders own 1.53% of the company’s stock.

Hedge Funds Weigh In On Medical Properties Trust

A number of large investors have recently bought and sold shares of the stock. Silver Point Capital L.P. raised its holdings in Medical Properties Trust by 155.3% in the third quarter. Silver Point Capital L.P. now owns 6,000,000 shares of the real estate investment trust’s stock valued at $35,100,000 after buying an additional 3,650,000 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its holdings in shares of Medical Properties Trust by 353.5% during the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 3,525,714 shares of the real estate investment trust’s stock valued at $20,625,000 after acquiring an additional 2,748,245 shares in the last quarter. Bank of New York Mellon Corp boosted its position in Medical Properties Trust by 22.6% during the 2nd quarter. Bank of New York Mellon Corp now owns 6,908,362 shares of the real estate investment trust’s stock worth $29,775,000 after purchasing an additional 1,274,481 shares during the period. Wilsey Asset Management Inc. increased its holdings in Medical Properties Trust by 27.2% in the 2nd quarter. Wilsey Asset Management Inc. now owns 4,376,180 shares of the real estate investment trust’s stock valued at $18,861,000 after purchasing an additional 936,631 shares in the last quarter. Finally, International Assets Investment Management LLC raised its position in Medical Properties Trust by 378.4% in the third quarter. International Assets Investment Management LLC now owns 885,983 shares of the real estate investment trust’s stock valued at $5,183,000 after purchasing an additional 700,783 shares during the period. Hedge funds and other institutional investors own 71.79% of the company’s stock.

Medical Properties Trust Company Profile

(Get Free Report

Medical Properties Trust, Inc is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities. From its inception in Birmingham, Alabama, the Company has grown to become one of the world's largest owners of hospital real estate with 441 facilities and approximately 44,000 licensed beds as of September 30, 2023.

Recommended Stories

Analyst Recommendations for Medical Properties Trust (NYSE:MPW)

Receive News & Ratings for Medical Properties Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Properties Trust and related companies with MarketBeat.com's FREE daily email newsletter.